HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Huabei Zhang Selected Research
Huabei Zhang Research Topics
Disease
13
Neoplasms (Cancer)
03/2024 - 01/2009
3
Alzheimer Disease (Alzheimer's Disease)
01/2021 - 12/2010
2
Atherosclerosis
01/2021 - 12/2009
1
Atherosclerotic Plaque (Atheroma)
01/2021
1
Nervous System Diseases (Neurological Disorders)
12/2019
1
Cognitive Dysfunction
11/2018
1
Glioma (Gliomas)
01/2018
1
Carcinoma (Carcinomatosis)
01/2018
1
Myocardial Ischemia (Ischemic Heart Diseases)
01/2017
1
Infections
01/2008
Drug/Important Bio-Agent (IBA)
5
Focal Adhesion Protein-Tyrosine Kinases
IBA
03/2024 - 02/2017
3
pyrimidine
IBA
01/2022 - 08/2016
3
Cholinergic Receptors
IBA
01/2021 - 11/2018
2
Phosphotransferases (Kinase)
IBA
03/2018 - 02/2017
2
Proteins (Proteins, Gene)
FDA Link
01/2018 - 12/2010
2
Radiopharmaceuticals
IBA
02/2017 - 10/2013
1
Enzymes
IBA
01/2022
1
Molecular Probes (Molecular Probe)
IBA
01/2021
1
2,4-diaminopyrimidine
IBA
01/2021
1
Apolipoproteins E (ApoE)
IBA
01/2021
1
Clerodane Diterpenes
IBA
11/2018
1
Diterpenes
IBA
11/2018
1
nonane
IBA
11/2018
1
PF-562271
IBA
03/2018
1
Salts
IBA
03/2018
1
abemaciclib
IBA
01/2018
1
palbociclib
IBA
01/2018
1
ribociclib
IBA
01/2018
1
Quinazolines
IBA
01/2018
1
Gefitinib (Iressa)
FDA Link
09/2017
1
N- methyl- N- (3- ((2- (2- oxo- 2,3- dihydro- 1H- indol- 5- ylamino)- 5- trifluoromethyl- pyrimidin- 4- ylamino)- methyl)- pyridin- 2- yl)- methanesulfonamide
IBA
02/2017
1
Pyrimidines
IBA
02/2017
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
02/2017
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2017
1
Mechlorethamine (Nitrogen Mustard)
FDA Link
08/2016
1
Fluorescein-5-isothiocyanate (FITC)
IBA
10/2013
1
Peptides (Polypeptides)
IBA
10/2013
1
Cytotoxins (Cytolysins)
IBA
09/2011
1
Flavones
IBA
12/2010
1
Ligands
IBA
12/2010
1
P-Selectin
IBA
12/2009
1
DNA (Deoxyribonucleic Acid)
IBA
01/2009
Therapy/Procedure
5
Therapeutics
03/2024 - 01/2008
1
Molecular Targeted Therapy
01/2021